Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bi-citrate
2. Biselic
3. Bismofarma
4. Bismuth Citrate
5. Bismuth Tripotassium Dicitrate
6. Colloidal Bismuth Subcitrate
7. De-nol
8. De-noltab
9. Denol
10. Gastrodenol
11. Sucrato
12. Tripotassium-dicitrato Bismuthate
13. Ventrisol-polfa
1. Gastrodenol
2. Bismuth Tripotassium Dicitrate
3. 57644-54-9
4. Colloidal Bismuth Subcitrate
5. Tripotassium Dicitratobismuthate
6. Hs813p8qpx
7. Bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate
8. Bismuth Subcitrate Potassium
9. De-noltab
10. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Potassium Salt (2:1:3)
11. Tripotassium;2-hydroxypropane-1,2,3-tricarboxylate;5-hydroxy-2,8,9-trioxa-1-bismabicyclo[3.3.2]decane-3,7,10-trione
12. Unii-hs813p8qpx
13. Einecs 260-872-5
14. De-nol (tn)
15. Tripotassium Dicitrate Bismuthate
16. Bismuth Subcitrate [vandf]
17. Bcp10508
18. Bismuth Subcitrate [who-dd]
19. Hy-b0796
20. Bismuth Subcitrate, Colloidal
21. Mfcd02101411
22. Akos005110988
23. Cs-3966
24. Colloidal Bismuth Subcitrate [mi]
25. B4377
26. Ft-0623129
27. D07587
28. Tripotassium Dicitratobismuthate [who-dd]
29. Bismuth(iii) Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
30. Bismuth(3+) Tripotassium Bis(2-hydroxypropane-1,2,3-tricarboxylate)
31. Bismuth Tripotassium Dicitrate; Bismuth Subcitrate; Duosol; Gastrodenol; Bismuth Subcitrate Potassium; De-nol
| Molecular Weight | 704.47 g/mol |
|---|---|
| Molecular Formula | C12H10BiK3O14 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 4 |
| Exact Mass | 703.87857 g/mol |
| Monoisotopic Mass | 703.87857 g/mol |
| Topological Polar Surface Area | 281 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 211 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 6 |
Antacids
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX05 - Bismuth subcitrate
API SUPPLIERS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8469
Submission : 1990-02-14
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12723
Submission : 1997-10-29
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Denol Swallow Tablets
Dosage Form : TAB
Dosage Strength : 120mg
Packaging : 40X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Ukraine
Brand Name : Vis-Nol
Dosage Form : Capsule
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Switzerland
Tetracyclini hydrochloridum; Bismuthi subcitras calicum; Metronidazolum
Brand Name : Pylera
Dosage Form : Caps
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Ukraine
Brand Name : Vis-Nol
Dosage Form : Capsule
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Switzerland
Tetracyclini hydrochloridum; Bismuthi subcitras calicum; Metronidazolum
Brand Name : Pylera
Dosage Form : Caps
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Denol Swallow Tablets
Dosage Form : TAB
Dosage Strength : 120mg
Packaging : 40X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
